Allied Market Research

2025

An Biomarkers Market

An Biomarkers Market, by Type of Biomarkers (Proteomics Biomarkers, Genomics Biomarkers, Metabolomics Biomarkers, Epigenomics Biomarkers, Pathway Biomarkers, Immunophenotyping Biomarkers) and, by Application (Drug Discovery, Diagnostics, Toxicology, Therapeutics): Opportunity Analysis and Industry Forecast, 2023-2032

MC : Other

Select an option
Author's: | Eswara Prasad
Publish Date:

Get Sample to Email

The study on the An biomarkers market offers insights, information, and recommendation to market stakeholders and investors to help them prioritize and formulate strategic decisions. The report includes An biomarkers market across more than 15 countries. The study is analyzed on the basis of rigorous research methodology, which covers extensive desk research using qualitative analysis, quantitative/statistical methods, and primary interviews.

The study analyzes the market scope, revenue size, and growth of the global An biomarkers market and monitors the prime trends at the regional level. In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. The report includes a section on the company profile that covers the company overview, company snapshot, key executives, product/service portfolio, operating business segments, business performance, R&D expenditure, and key strategic moves & developments. The global An biomarkers market is categorized on the basis of by type of biomarkers, by application. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Spain, Italy, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Key players covered in this report are Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Danaher Corp., Exide Technologies, Roche Diagnostics, Johnson and Johnson, Siemens AG, Thermo Fisher Scientific, Agilent Technologies Inc.

Deliverables:

  • Market size value forecast by country

  • Regional-level market trends and market dynamics

  • Porter’s five forces model and PESTLE Analysis

  • Company profile, competition landscape inclusive of heatmap analysis, competition dashboard and product/service offerings

  • Major developmental strategies and M&A activities

  • Country-wise market size and forecast for each segment

  • Market share of leading players worldwide

Market Taxonomy

This report divides the global An biomarkers market on the basis of by type of biomarkers, by application. On the basis of region, the global An biomarkers market analyzed across North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa.

An Biomarkers Market Report Highlights

Aspects Details
icon_5
By Type of Biomarkers
  • Proteomics Biomarkers
  • Genomics Biomarkers
  • Metabolomics Biomarkers
  • Epigenomics Biomarkers
  • Pathway Biomarkers
  • Immunophenotyping Biomarkers
icon_6
By Application
  • Drug Discovery
  • Diagnostics
  • Toxicology
  • Therapeutics
icon_7
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_8
Key Market Players

Thermo Fisher Scientific Inc., Beckman Coulter Inc., Siemens AG, Roche Diagnostics, Agilent Technologies Inc., Johnson and Johnson, Danaher Corp., Bio-Rad Laboratories Inc., Abbott Laboratories, Exide Technologies

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

An Biomarkers Market

Opportunity Analysis and Industry Forecast, 2023-2032